NCT07284667 Phase 2 Recruiting
ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response Study sponsor: ACADIA Pharmaceuticals Inc. · ACAD
Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.
Changes Study details Primary completion 2027-08 Estimated
Enrollment · participants 153 Estimated
Source updated 2026-09-14 Last update listed in the registry record
Version history
Changes to this trial Last 12 months Posted 2026-07-16 · 1 field changed
Primary outcomes · main study measures Text edit · unverified significance − Previous value measure: Change from Baseline in the Montgomery-Åsberg Depression Rating Scale (MADRS) total score at Day 28
+ Updated value measure: Change From Baseline in Montgomery-Åsberg Depression Rating Scale (MADRS) Total Score at Day 28
The saved outcome text may be shortened. Check the source for full wording.
Check registry source This database covers selected trials and recorded edits. Some past edits may be missing, and saved text about the main study measures (endpoints) may be shortened. Check the original registry record when a detail matters. Read our methodology
Trial